CLK is a dual-specificity protein kinase capable of phosphorylating serine, threonine, and tyrosine residues.
The biological events leading to the acquisition of a neuronal phenotype have been extensively studied; however, it remains unclear how neuronal stem cell populations are instructed to withdraw from the cell cycle and selectively express neuronal cell-specific genes. The ability of nerve growth factor (NGF) to elicit such changes in the clonal rat pheochromocytoma (PC12) cell line has allowed the use of this model system for the biochemical investigation of these events (26) . Like neuronal stem cells, PC12 cells can either exit the cell cycle and terminally differentiate or continue to proliferate in a nondifferentiated state. NGF stimulation of PC12 cells initially prompts the cells to undergo a final round of mitosis, followed by withdrawal of the cells from the cell cycle. NGF treatment provokes the stimulation of multiple independent signaling pathways leading to phenotypic changes, including the development of synaptic vesicles, electrical excitability (22) , and the elaboration of neurites (26) .
NGF initiates its actions through binding to the trkA protooncogene. The trkA receptor possesses a tyrosine kinase domain whose activity is stimulated upon NGF binding (28, (36) (37) (38) . Activation of the trkA receptor kinase leads to the tyrosine autophosphorylation of trkA and the subsequent association of SH2 domain-containing adapter and effector proteins with the receptor (53) . Recent studies have defined a trkA-dependent proto-oncogene signaling cascade that results in the activation of p2lras (20, 39) . Activation of p2lras results in the serial activation of serine/threonine kinases including the raf kinases, MEK1, the mitogen-activated protein (MAP) kinases (ERK1 and ERK2), and pp9ORSK (20, 33, 49, 58, 60) . The p21ras-dependent serine/threonine kinase cascades appear to be a major avenue responsible for transmission of intracellular signals from the membrane to the nucleus (21) .
It has recently been recognized that several growth factorstimulated kinases are members of the newly described class of dual-specificity kinases that have the capacity to phosphorylate serine, threonine, and tyrosine residues (44) . Heretofore, protein kinases have been thought to be segregated into two distinct and nonoverlapping groups based on conserved amino acid motifs that were used to predict their ability to phosphorylate either serine/threonine residues or tyrosine residues (27, 44) . On the basis of their primary amino acid sequences, the dual-specificity kinases are indistinguishable from serine/ threonine kinases (44) . However, their ability to phosphorylate tyrosine residues has forced a reevaluation of intracellular signaling pathways, since it was believed that only tyrosine kinases could be responsible for these modifications.
The first identification of a dual-specificity kinase came with the cloning of CLK (cdc2-like kinase) (6, 30, 35) . CLK was isolated by screening expression libraries with antiphosphotyrosine antibodies and was subsequently shown to phosphorylate itself, as well as exogenous substrates, on both serine and tyrosine residues (6, 30) . The highest levels of CLK expression were found in the brain (30) . Moreover, differentiation of P19 embryonic carcinoma cells into a neural phenotype was found to be accompanied by the enhanced expression of CLK mRNA (30) . However, these data provided few insights into the physiological function of CLK.
The recognition that the dual-specificity protein kinases are critical intermediates in the transduction of intracellular signals and their potential role during neuronal development (30) led us to investigate the capacity of the prototypic dualspecificity kinase, CLK, to intervene in NGF-mediated signaling events. We report here that expression of CLK in PC12 cells resulted in the selective activation of growth factordependent kinase cascades and resulted in the morphological differentiation of PC12 cells, indicating that CLK may function as a component of growth factor-dependent signal transduction cascades.
MATERUILS AND METHODS
Cell culture and generation of CLK-expressing lines. PC12 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal calf serum and 10% donor horse serum in an atmosphere of 10% CO2. PC-CLK lines were generated by electroporating PC12 cells with a pNeoNut construct containing the full-length CLK cDNA cloned downstream of the metallothionine-1 (MT-1) promoter (17) . Stably transfected PC12 cell lines were established by electroporating PC12 cells with the pNeoNut vector alone (16) 35 min, the supernatants were applied to a MonoQ HR5/5 fast protein liquid chromatography column (Pharmacia) that had been preequilibrated with buffer A. The column was washed with 5 ml of buffer A and then developed with a linear 0 to 0.5 M NaCl gradient, and 1-ml fractions were collected, as previously described (34 temperature. MBP assays were stopped by the addition of concentrated Laemmli sample buffer, mixtures were boiled for 5 min, and the reaction products were separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. The bands corresponding to MBP were cut from the gel, and the incorporated radioactivity was measured by Cerenkov counting. S6 peptide assays were stopped by the addition of trichloroacetic acid to 3.5% and bovine serum albumin to 0.2 mg/ml, and mixtures were incubated for 15 min on ice as previously described (57) . After centrifugation at 10,000 x g for 5 min, aliquots of the supernatants were spotted onto Whatman P-81 paper and washed three times for 5 min each time with 75 mM phosphoric acid (25) . The incorporated radioactivity was measured by Cerenkov counting.
Immunoblotting. Fractions obtained from the MonoQ chromatography were trichloroacetic acid precipitated, and the proteins were separated by SDS-polyacrylamide gel electrophoresis and then transferred to an Immobilon P membrane as previously described (34) . The blots were probed with pp70S6K antisera provided by J. Avruch, pp9O's antisera purchased from UBI, the antiphosphotyrosine antibodies purchased from Signal Transduction Laboratories, and MAP kinase antisera purchased from Bio-Designs, Inc. The immunoreactive species were detected with horseradish peroxidase-conjugated secondary antibodies and visualized with enhanced chemiluminescence reagents obtained from Amersham.
RESULTS
Expression of CLK in PC12 cells. We established PC12 cell lines stably expressing CLK under the control of the MT-1 promoter. Two cell lines, PC-CLK4 and PC-CLK6, were selected for further characterization on the basis of their phenotypic response to Zn2+. Incubation of PC-CLK4 and PC-CLK6 cells in the presence of Zn2+ resulted in the transient induction of CLK mRNA (Fig. 1A) . CLK mRNA levels were maximal within 3 h and then declined over the next several hours, but they were still detectable for at least 24 Zn2+-treated PC-CLK4 cells possessed a robust MBP activity not present in uninduced PC-CLK4 cells, in the parental PC12 cell line, or in vector-only transfectants. The detection of CLK activity was coincident with the de novo appearance of a 55-kDa tyrosine-phosphorylated protein (Fig. 1B and C (Fig. 2) . The CLK-mediated neurite outgrowth of PC-CLK4 cells occurred more slowly than that induced by NGF (Fig. 3) , and the neurites were shorter (Fig. 2) but were otherwise indistinguishable from neurites elicited by NGF. Importantly, Zn2+ treatment of the parental PC12 cells or cell lines transfected with the vector only did not result in neuronal differentiation. These cells, however, retained normal responsiveness to NGF (Fig. 3) , indicating that the Zn2+-induced neuronal differentiation seen in PC-CLK4 cells was not due to nonspecific cellular responses to potentially toxic heavy metals. PC-CLK6 cells also elaborated neurites in response to Zn2+ treatment, but to a lesser degree than did the PC-CLK4 cells (data not shown), which is reflected in the different levels of CLK mRNA induced by Zn2+ treatment (Fig. 1A) . Because of their more robust response to Zn2+ treatment, PC-CLK4 cells were used in all subsequent studies.
CLK enhancement of NGF-mediated neurite outgrowth. The observation that CLK expression provoked the morphological differentiation of PC-CLK4 cells led us to question whether CLK expression could enhance subsequent NGF action, in a manner similar to that of NGF pretreatment (10) . Pretreatment of PC-CLK4 cells with Zn2+ for 2 days resulted in an accelerated response to NGF (Fig. 3A) . Importantly, Zn2+ treatment did not alter the rate of NGF-mediated neurite outgrowth in either the parental PC12 cell line or cells transfected with the vector alone (Fig. 3) . These data demonstrate that the enhancement of neurite outgrowth was caused by the induction of CLK expression and not by nonspecific cellular responses to Zn2+.
PC-CLK4 cells responded more quickly to NGF than did the cell lines transfected with the vector alone or the parental PC12 cell line. Moreover, Zn2+ treatment enhanced neurite outgrowth only from the PC-CLK4 cells (Fig. 3A) . The accelerated response to NGF by untreated PC-CLK4 cells may be caused either by the selection of a more rapidly responding clone or, more likely, by low levels of CLK expressed by the notoriously leaky MT-1 promoter (16) .
Effect of CLK expression on cell survival. PC12 cells normally require serum for survival and die within 96 h in its absence (51) . NGF, however, has been shown to support the survival of these cells in serum-free media (51) . We tested whether the induction of CLK expression was sufficient to sustain these cells upon serum withdrawal, mimicking another effect of NGF. PC-CLK4 cells were incubated for 4 days in the presence of 5 ,uM Zn2+ and were then incubated in the presence or absence of Zn2+ in serum-free media for various times, after which the number of surviving cells was determined. In contrast to CLK's capacity to augment the action of NGF on the differentiation of PC12 cells, Zn2'-treated PC-CLK4 cells died as rapidly in the absence of serum as did the parental PC12 cells and the PC12 cells transfected with the vector alone (Fig. 4 ). These data demonstrate that CLK does not promote the serum-free survival of PC12 cells. Moreover, CLK served to stimulate the morphological differentiation of these cells without also promoting their survival. These data suggest that CLK cannot reproduce the entire range of NGF m~~: Wy (57) . CLK expression resulted in the stimulation of MAP kinase activities ( Fig. 5B and C) , reflecting the activation of ERKi by 15-fold and ERK2 by 5-fold. Similarly, pp9ORsK
activity was stimulated sevenfold in the CLK-expressing cells ( Fig. SA and C) . This latter observation is consistent with the capacity of the MAP kinases to directly phosphorylate and pp9ORSK-_ _ ERK1-ERK2-activate pp9ORSK (13, 15) . Another S6 peptide kinase activity, termed S6PKII, was stimulated 18-fold upon induction of CLK ( Fig. 5A and C) . S6PKII represents a poorly characterized growth factor-responsive kinase previously reported in a number of studies (1, 24) . The activation of these enzymes was a consequence of CLK expression, as Zn2+ treatment of the parental PC12 cells or cells transfected only with the vector did not stimulate MAP kinase activity and resulted in only a modest increase in pp9ORSK activity and S6PKII (Fig. 5C ).
The effect of CLK expression on NGF-dependent serine/ threonine kinases was specific, as Zn2+ treatment of PC-CLK4 cells and the parental PC12 cells had only a small effect on the activities of pp7OS6K (Fig. 5A and C) and Fos kinase (data not shown), which were stimulated to almost the same degree. The response of cellular kinases to Zn2+ is most likely due to the ability of Zn2+ to effect both protein kinase activity (3) and phosphatase activity (9) . These data confirm that CLK expression stimulated only a subset of the biochemical pathways utilized by NGF.
DISCUSSION
The existence of dual-specificity protein kinases was first suggested by the observation that the Schizosaccharomyces pombe weel gene product functionally inactivated cdc2-cyclin B complexes through the threonine and tyrosine phosphorylation of cdc2 (23, 47, 52) . Subsequently, it has been shown that the dual-specificity kinases also play a central role in the initiation and maintenance of growth factor-mediated signal transduction. The activin type II receptor (46) and the MAP kinases (18) and their upstream activator, MEK1 (also termed MAP kinase kinase), are dual-specificity kinases (18, 19 Western blotted and reacted with anti-ERK antibodies to verify the identity of these species. (C) Bar graph illustrating the Zn2+-induced activation of the peak fractions corresponding to ppg9RSK, S6PKII, pp7OS6K, ERK1, and ERK2.
transcription through the phosphorylation of a growing number of transcription factors (21, 31) .
The present data provide direct evidence that expression of CLK mimicked a number of the actions of NGF, with respect to both the induction of morphological differentiation of PC12 cells and the capacity to activate protein kinases which are central elements of NGF-stimulated signal transduction pathways. The ability of CLK to stimulate the acquisition of a neuronal phenotype in PC12 cells may be of particular significance, given that the brain normally expresses CLK at much greater levels than other tissues (30) . It is also of interest that the differentiation of P19 embryonal carcinoma cells to a neural phenotype is accompanied by a dramatic stimulation of CLK expression (30) .
The CLK-induced morphological differentiation of PC12 cells is similar to that produced upon expression of the proto-oncogenes v-src (2), Ha-ras (5), v-crk (56) , and shc (50) or oncogenic RAF (RAF-1) alleles (61) . The induction of neuronal differentiation in PC12 cells is a specific response, as other ligands, such as insulin, phorbol esters, and epidermal growth factor (11), do not result in the differentiation of PC12 cells or augment the action of subsequent NGF treatment (10 The mechanisms by which CLK activity is regulated and the positions within the signal transduction cascade where CLK acts are currently unknown. The trkA-mediated signals responsible for the activation of serine/threonine kinases and the acquisition of neuronal properties have been shown to be conveyed through pp6Q"rc, p2lras, and raf (20, 39) . Recently, a number of groups have shown that the raf kinases directly associate with activated p2lras (33, 45, 59 ) and can activate the MAP kinase activator, MEK1 (29, 40) , leading to the serial activation of the MAP kinases and pp9ORSK. The ability of CLK to phosphorylate serine/threonine residues, as well as tyrosine residues, suggests that CLK could intervene at a number of places in the NGF-dependent signal transduction cascade. Most notably, activations of the MAP kinases (29, 40, 48) and their activator, MEK1 (5, 34) , have been shown to be dependent on both serine/threonine and tyrosine phosphorylation. The activation of this cascade by a differentiationspecific stimulus, CLK, supports the importance of the MAP kinase cascade in mediating the morphological differentiation of PC12 cells (34, 58, 60) .
Recently, Lange-Carter et al. (43) have described an alternate pathway leading to the activation of the MAP kinase cascade. In this pathway, MEK is activated by MEKK rather than by raf. This MEKK-dependent pathway is believed to be regulated by G-protein-linked receptors rather than by tyrosine kinase-linked receptors (43) . The presence of this pathway, along with multiple MEK, and presumably MEKK, isoforms adds to the potential sites of CLK intervention in the intracellular signaling cascade.
An important feature of these studies is that a wild-type allele of CLK was employed in these experiments. The use of a nonactivated (i.e., oncogenic) allele makes it unlikely that the effects seen here are due to nonspecific interactions driven by a hyperactive kinase. The inability of CLK to activate Fos kinase or pp7OS6K is of particular significance, as it directly demonstrated that CLK selectively regulates the avenues through which serine/threonine kinases act to effect the biological actions of growth factors. pp7OS6K and Fos kinase are, however, components of the normal cellular responsiveness to NGF and other growth factors (42, 57) . The ability of CLK to activate the MAP kinase cascade while failing to activate pp70S6K is not too surprising, as these kinases are regulated by distinct signaling events (4, 7, 14) . The inability of CLK expression to activate pp70S6K and Fos kinase suggests that the activation of these protein kinases is not absolutely necessary for the morphological differentiation of PC12 cells.
CLK is not normally expressed in PC12 cells and therefore does not participate in NGF-mediated signal transduction. CLK's responsiveness to differentiative stimuli in P19 cells (30) and CLK's ability to differentiate PC12 cells suggest that CLK may normally act to promote and maintain the differentiated phenotype in the nervous system. The ability of CLK to participate in signal transduction pathways is consistent with the actions of its structural homologues, cdc2 (6, 35) and the MAP kinases (8) . The ability of CLK to selectively intervene within NGF signaling pathways suggests that CLK may also participate in growth factor signaling in other cell types.
